Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [(18)F]UCB-H PET imaging

OBJECTIVE: In preclinical research, the use of [(18)F]Fluorodesoxyglucose (FDG) as a biomarker for neurodegeneration may induce bias due to enhanced glucose uptake by immune cells. In this study, we sought to investigate synaptic vesicle glycoprotein 2A (SV2A) PET with [(18)F]UCB-H as an alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogler, Letizia, Ballweg, Anna, Bohr, Bernd, Briel, Nils, Wind, Karin, Antons, Melissa, Kunze, Lea H., Gnörich, Johannes, Lindner, Simon, Gildehaus, Franz-Josef, Baumann, Karlheinz, Bartenstein, Peter, Boening, Guido, Ziegler, Sibylle I., Levin, Johannes, Zwergal, Andreas, Höglinger, Günter U., Herms, Jochen, Brendel, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407951/
https://www.ncbi.nlm.nih.gov/pubmed/37541098
http://dx.doi.org/10.1016/j.nicl.2023.103484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407951/
https://www.ncbi.nlm.nih.gov/pubmed/37541098
http://dx.doi.org/10.1016/j.nicl.2023.103484

Ejemplares similares